Anthony Robert Sheets, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Extracellular Matrix | 2 | 2016 | 1739 | 0.610 |
Why?
|
| Pericytes | 2 | 2016 | 299 | 0.520 |
Why?
|
| Collagenases | 1 | 2016 | 221 | 0.510 |
Why?
|
| Peptides | 2 | 2016 | 4353 | 0.460 |
Why?
|
| Neovascularization, Physiologic | 2 | 2016 | 1371 | 0.390 |
Why?
|
| Organ Specificity | 1 | 2016 | 1970 | 0.380 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2016 | 1124 | 0.340 |
Why?
|
| Lipid Mobilization | 1 | 2008 | 17 | 0.310 |
Why?
|
| Wound Healing | 2 | 2016 | 2815 | 0.300 |
Why?
|
| Endothelial Cells | 3 | 2021 | 3591 | 0.280 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2008 | 394 | 0.260 |
Why?
|
| Mitochondrial Proteins | 2 | 2008 | 980 | 0.240 |
Why?
|
| Fatty Liver | 2 | 2008 | 810 | 0.230 |
Why?
|
| Ion Channels | 2 | 2008 | 1044 | 0.220 |
Why?
|
| Endothelium, Vascular | 1 | 2016 | 4428 | 0.220 |
Why?
|
| Fasting | 1 | 2008 | 1610 | 0.190 |
Why?
|
| Eczema | 1 | 2024 | 245 | 0.190 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2024 | 572 | 0.170 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2021 | 213 | 0.170 |
Why?
|
| Edema | 1 | 2023 | 766 | 0.160 |
Why?
|
| Calciphylaxis | 1 | 2021 | 129 | 0.160 |
Why?
|
| Quinoxalines | 1 | 2021 | 297 | 0.160 |
Why?
|
| Pulmonary Circulation | 1 | 2021 | 744 | 0.150 |
Why?
|
| Deoxyuridine | 1 | 2016 | 34 | 0.130 |
Why?
|
| Microbial Collagenase | 1 | 2016 | 112 | 0.130 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2016 | 222 | 0.130 |
Why?
|
| Staphylococcus aureus | 1 | 2024 | 1430 | 0.130 |
Why?
|
| Neovascularization, Pathologic | 2 | 2016 | 2634 | 0.120 |
Why?
|
| Coculture Techniques | 2 | 2016 | 1342 | 0.120 |
Why?
|
| Sus scrofa | 1 | 2016 | 430 | 0.120 |
Why?
|
| Cell Adhesion | 1 | 2021 | 3102 | 0.120 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2016 | 254 | 0.120 |
Why?
|
| Chemokine CXCL12 | 1 | 2016 | 457 | 0.110 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2023 | 2433 | 0.110 |
Why?
|
| Models, Animal | 2 | 2021 | 2123 | 0.110 |
Why?
|
| Debridement | 1 | 2016 | 494 | 0.110 |
Why?
|
| Epidermal Growth Factor | 1 | 2016 | 697 | 0.110 |
Why?
|
| Chemotaxis | 1 | 2016 | 600 | 0.110 |
Why?
|
| Skin | 2 | 2024 | 4507 | 0.100 |
Why?
|
| Mice, Knockout | 2 | 2024 | 14485 | 0.100 |
Why?
|
| Liver | 1 | 2008 | 7579 | 0.100 |
Why?
|
| Keratinocytes | 1 | 2016 | 876 | 0.100 |
Why?
|
| Receptors, CXCR4 | 1 | 2016 | 729 | 0.090 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2021 | 2911 | 0.090 |
Why?
|
| Pyrazoles | 1 | 2021 | 2029 | 0.090 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2024 | 3116 | 0.090 |
Why?
|
| Cell Communication | 1 | 2016 | 1660 | 0.080 |
Why?
|
| Pulmonary Embolism | 1 | 2021 | 2598 | 0.070 |
Why?
|
| Cell Cycle | 1 | 2016 | 2937 | 0.070 |
Why?
|
| Regeneration | 1 | 2016 | 1524 | 0.070 |
Why?
|
| Cells, Cultured | 3 | 2021 | 19023 | 0.070 |
Why?
|
| Fibroblasts | 1 | 2016 | 4178 | 0.060 |
Why?
|
| Diabetic Retinopathy | 1 | 2015 | 1299 | 0.060 |
Why?
|
| Signal Transduction | 2 | 2021 | 23652 | 0.060 |
Why?
|
| Amino Acid Sequence | 1 | 2016 | 13427 | 0.060 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2008 | 1169 | 0.050 |
Why?
|
| Cell Proliferation | 2 | 2016 | 10486 | 0.050 |
Why?
|
| Mice | 5 | 2024 | 82074 | 0.050 |
Why?
|
| Animals | 6 | 2024 | 169408 | 0.050 |
Why?
|
| Oxidation-Reduction | 1 | 2008 | 2226 | 0.050 |
Why?
|
| RNA, Messenger | 1 | 2016 | 12809 | 0.050 |
Why?
|
| Adaptation, Physiological | 1 | 2008 | 1315 | 0.050 |
Why?
|
| Membrane Transport Proteins | 1 | 2006 | 1039 | 0.040 |
Why?
|
| Thigh | 1 | 2021 | 239 | 0.040 |
Why?
|
| Upper Extremity | 1 | 2023 | 683 | 0.040 |
Why?
|
| Dermatitis, Atopic | 1 | 2024 | 737 | 0.030 |
Why?
|
| Cholangiocarcinoma | 1 | 2021 | 562 | 0.030 |
Why?
|
| Bile Duct Neoplasms | 1 | 2021 | 615 | 0.030 |
Why?
|
| Receptors, Lysosphingolipid | 1 | 2015 | 123 | 0.030 |
Why?
|
| Connexin 43 | 1 | 2015 | 202 | 0.030 |
Why?
|
| Humans | 8 | 2024 | 768887 | 0.030 |
Why?
|
| Gene Expression | 1 | 2006 | 7602 | 0.030 |
Why?
|
| Insulin | 1 | 2008 | 6610 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2008 | 6434 | 0.030 |
Why?
|
| Sphingosine | 1 | 2015 | 308 | 0.030 |
Why?
|
| Lysophospholipids | 1 | 2015 | 338 | 0.030 |
Why?
|
| DNA | 1 | 2006 | 7214 | 0.030 |
Why?
|
| Blood Platelets | 1 | 2021 | 2479 | 0.020 |
Why?
|
| Cytoskeleton | 1 | 2015 | 1180 | 0.020 |
Why?
|
| Biopsy | 1 | 2021 | 6805 | 0.020 |
Why?
|
| Female | 5 | 2024 | 397464 | 0.020 |
Why?
|
| Actins | 1 | 2015 | 2065 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2015 | 5035 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2023 | 5707 | 0.020 |
Why?
|
| Time Factors | 1 | 2008 | 40266 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2024 | 22381 | 0.020 |
Why?
|
| Retina | 1 | 2015 | 2661 | 0.010 |
Why?
|
| Male | 3 | 2024 | 365249 | 0.010 |
Why?
|
| Adult | 1 | 2016 | 223818 | 0.010 |
Why?
|
| Hepatocytes | 1 | 2006 | 1246 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2006 | 6085 | 0.010 |
Why?
|
| Acute Disease | 1 | 2006 | 7245 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2006 | 3138 | 0.010 |
Why?
|
| Apoptosis | 1 | 2006 | 9528 | 0.010 |
Why?
|
| Aged | 1 | 2021 | 171790 | 0.000 |
Why?
|
| Disease Models, Animal | 1 | 2006 | 18366 | 0.000 |
Why?
|
| Middle Aged | 1 | 2021 | 223740 | 0.000 |
Why?
|